Tech Company Financing Transactions
Avid Radiopharmaceuticals Funding Round
On 12/31/2009, Avid Radiopharmaceuticals announced $15.4 million in investment from Alta Partners, Riverwood Capital and Safeguard Scientifics.
Transaction Overview
Company Name
Announced On
12/31/2009
Transaction Type
Venture Equity
Amount
$15,363,000
Round
Undisclosed
Investors
Proceeds Purpose
Proceeds purposes were not disclosed.
Company Information
Company Status
Acquired or Merged
Industry
Biopharmaceutical
Mailing Address
3711 Market St. 710
Philadelphia, PA 19104
USA
Philadelphia, PA 19104
USA
Phone
Website
Email Address
Overview
Avid Radiopharmaceuticals, Inc. is a clinical-stage product-focused molecular imaging company that has assembled world-class expertise and IP in the field of molecular brain imaging. Avid has developed proprietary radiopharmaceuticals to image amyloid plaques and is currently testing these agents in clinical trials for the detection of Alzheimer's disease.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Daniel Skovronsky
Chief Financial Officer
Richard Baron
Chief Scientific Officer
Franz Hefti
Vice President
Michael Pontecorvo
VP - Bus. Development
Alan Carpenter
VP - Manufacturing
Paul Kennedy
Browse more venture capital transactions:
Prev: 12/31/2009: BlueJeans venture capital transaction
Next: 12/31/2009: Vast venture capital transaction
Share this article
Where The Data Comes From
We do our best to report on every notable VC transaction. VC investment data records reported here are sourced from company press releases and news coverage. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs